4 hours ago AHRQ has responsibility for listing and delisting of patient safety organizations (PSOs) described in Subpart B. Subpart A defines essential terms, such as patient safety work product, patient safety evaluation system, and PSO. Subpart B provides the requirements for listing PSOs. These entities offer their expert advice in analyzing the patient safety events and other information … >> Go To The Portal
The Patient Safety Rule requires an entity to certify that it meets 15 distinct statutory requirements; a component of another organization must attest that it meets another three statutory requirements; and each entity or component organization must comply with several additional regulatory requirements.
The Patient Safety Rule. The Patient Safety Rule, published in the Federal Register on November 21, 2008, effective on January 19, 2009, is codified at 42 C.F.R. Part 3 (73 FR 70732). The Patient Safety Rule implements select provisions of PSQIA. OCR has responsibility for interpreting and implementing the confidentiality protections described...
For more information on the Act and how organizations can become PSOs, go to the Web site: https://pso.ahrq.gov. What specific protections does the Patient Safety Act and Rule provide?
Steven Gans, MD is board-certified in psychiatry and is an active supervisor, teacher, and mentor at Massachusetts General Hospital. Mandated reporting refers to the legal obligation to report abuse. Mandated reporters are individuals or agencies that are legally required to make these reports.
Congress vested the authority for implementing the Patient Safety Act with AHRQ by incorporating its provisions into AHRQ's authorizing statute. As the lead Federal agency for patient safety research, AHRQ is an appropriate partner for PSOs and healthcare providers.
Patient Safety Organizations (PSOs) collect and analyze data voluntarily reported by healthcare providers to help improve patient safety and healthcare quality. PSOs provide feedback to healthcare providers aimed at promoting learning and preventing future patient safety events.
The Agency for Healthcare Research and Quality (AHRQ) is the lead federal agency charged with improving the quality and safety of America's health-care system.
Final Report to Congress To Improve Patient Safety Outlines Strategies To Speed Progress. A final report (PDF, 1.16 MB) on strategies to improve patient safety and reduce medical errors has been delivered to Congress by the U.S. Department of Health and Human Services in consultation with AHRQ.
A healthcare provider can only obtain the confidentiality and privilege protections of the Patient Safety Act by working with a Federally-listed PSO. Use the categories on the left to filter the list of PSOs or search a PSO name. There are 96 total PSOs listed by AHRQ.
U.S. Department of Health and Human Services (DHHS), National Institute for Occupational Safety and Health (NIOSH) Publication Number 2015-115, (October 2021). NIOSH/OSHA/CDC Toolkit.
OSHA started as a result of so many work accidents "More workers are injured in the healthcare and social assistance industry sector than any other.
The Agency for Healthcare Research and Quality (AHRQ) is the lead Federal agency charged with improving the safety and quality of healthcare for all Americans.
The Patient Safety Organization (PSO) program established federally recognized PSOs to work with health care providers to improve the safety and quality of patient care. The program also creates the first and only comprehensive, nationwide patient safety reporting and learning system in the United States.
What reports are encourage as a result of the patient safety and quality improvement act? near misses, unsafe conditions, adverse events, events the threaten patient safety.
The Patient Safety and Quality Improvement Act of 2005 (PSQIA) establishes a voluntary reporting system designed to enhance the data available to assess and resolve patient safety and health care quality issues.
Sen. Jim JeffordsThe PSQIA was introduced by Sen. Jim Jeffords [I-VT]. It passed in the Senate July 21, 2005 by unanimous consent, and passed the House of Representatives on July 27, 2005, with 428 Ayes, 3 Nays, and 2 Present/Not Voting.
To implement the Patient Safety Act, the Department of Health and Human Services' (HHS) Agency for Healthcare Research and Quality (AHRQ) published the Patient Safety and Quality Improvement Final Rule (Patient Safety Rule). AHRQ has received many questions regarding the implementation of the Patient Safety Rule and about PSOs.
Often referred to as the Patient Safety Act, the provisions of this law dealing with PSOs are administered by the Agency for Healthcare Research and Quality (AHRQ) and the provisions dealing with its confidentiality protections are interpreted and enforced by the Office for Civil Rights (OCR).
The PSO readmissions Web page contains helpful information and tools that can be used by such hospitals, and PSOs that work with those hospitals, to address the causes of unnecessary readmissions. In fact, any hospital can work with a PSO on any patient safety issue of the hospital's choice.
The uniform Federal protections that apply to a provider's relationship with a PSO are expected to remove significant barriers that can deter the participation of healthcare providers in patient safety and quality improvement initiatives , such as fear of legal liability or professional sanctions.
The Patient Safety Act and Rule provide protections that are designed to allay fears of providers of increased risk of liability if they voluntarily participate in the collection and analysis of patient safety events.
OCR is responsible for the investigation and enforcement of the confidentiality provisions of the Patient Safety Rule. OCR will investigate allegations of violations of confidentiality through a complaint-driven system.
The Patient Safety Rule requires an entity to certify that it meets 15 distinct statutory requirements; a component of another organization must attest that it meets another three statutory requirements; and each entity or component organization must comply with several additional regulatory requirements.
The Patient Safety Rule, published in the Federal Register on November 21, 2008, effective on January 19, 2009, is codified at 42 C.F.R. Part 3 (73 FR 70732). The Patient Safety Rule implements select provisions of PSQIA. OCR has responsibility for interpreting and implementing the confidentiality protections described in Subpart C and ...
AHRQ has responsibility for listing and delisting of patient safety organizations (PSOs) described in Subpart B. Subpart A defines essential terms, such as patient safety work product, patient safety evaluation system, and PSO.
The National Patient Safety Foundation has been pursuing one mission since its founding in 1997—to improve the safety of care provided to patients. As a central voice for patient safety, NPSF is committed to a collaborative, inclusive, multi-stakeholder approach in all that it does.
Partnership for Patient Safety is a patient-centered initiative to advance the reliability of healthcare systems worldwide. p4ps® initiates focused partnerships and joint ventures with organizations and individuals that share our core values and objectives of achieving a healthcare system that is authentically patient-centered and systems based.
The APSF’s Mission is to improve continually the safety of patients during anesthesia care by encouraging and conducting: 1 safety research and education; 2 patient safety programs and campaigns; 3 national and international exchange of information and ideas.
Danish Society for Patient Safety. December 14, 2012. The Danish Society for Patient Safety (DSFP) was established December 2001 and is a non-profit organization. The aim of the Society is to ensure that patient safety aspects are a part of all decisions made in Danish health care .
A “fair and just culture” in health care organizations is characterized by everyone throughout the organization being aware that medical errors are inevitable, but by reporting all errors and unintended events – even when the events may not cause patient injury – they can make the system safer. Read more.
The Health Foundation is an independent charity working to continuously improve the quality of healthcare in the UK. We want the UK to have a healthcare system of the highest possible quality – safe, effective, person-centered, timely, efficient and equitable.
The Nursing and Physician Leadership Congress is designed to help clinical leaders become catalysts for leading change. It provides nurse and physician executives an opportunity to share practical experience and brainstorm to develop interdisciplinary solutions to the healthcare industry’s most pressing problems. The focus on practical experience over policy and theory, along with ample opportunity to network with other senior clinical executives, distinguishes the Nurse and Physician Leadership Congress from other forums.
Nursing peer review is the evaluation of nursing services, the qualifications of a nurse, the quality of patient care rendered by a nurse, the merits of a complaint concerning a nurse or nursing care, and a determination or recommendation regarding a complaint including:
a report made by a nursing peer review committee to another committee or to the Board ofNursing (Board) as permitted or required by law; implementation of a duty of a nursing peer review committee by a member, an agent, or anemployee of the committee; and.
If a nurse commits five minor incidents within a 12-month period, the nurse must be reported to the nursing peer review in practice settings with nursing peer review. In practice settings with no nursing peer review, the nurse who commits five minor incidents within a 12-month period must be reported to the Board.
The nurse involved in either type of nursing peer review must agree to the use of the informal workgroup. The nurse does not give up his/her right to review by the full nursing peer review committee because they initially agree to the informal review process utilizing a workgroup of the nursing peer review committee.
A member, agent, or employee of a nursing peer review committee or a participant in a proceeding before the committee may not disclose or be required to disclose a communication made to the committee or a record or proceeding of the committee.
Since laws vary by state, there are some jurisdictional differences about who is required to make these reports. Typically, this includes the following individuals:
Although states vary on the specifics, mandated reporters exist to ensure safety by reporting suspected abuse. The local department of human services (sometimes called Child Protective Services or Department of Social Services) investigates the report and determines whether intervention is necessary.
Sometimes, information might not fall under mandated reporting, but an individual might still disclose it for safety or legal reasons.
The goal of mandated reporting is to ensure safety for vulnerable populations and prevent abuse. To learn more about your state's mandated reporting laws, check your government website. You can learn what circumstances require a report and which professionals and organizations are mandated reporters.
PSOs, and entities that seek to be PSOs, are reminded that an enti ty that is a unit or division of a legal entity, or that is owned, managed or controlled by one or more legally separate parent organizations, and that seeks to be a PSO, must apply as a component PSO. Thus, an entity that would be operating as a PSO and that is part of a larger organization that engages in FDA-regulated reporting activities, or that has a parent organization that engages in FDA-regulated reporting activities must seek listing as a component PSO. In addition, under 42 U.S.C. 299b-24(b)(1)(A), a PSO’s mission and primary activity must be to conduct activities to improve patient safety and the quality of health care delivery. Seeking listing as a component PSO helps to ensure that entities with multiple missions and activities (such as FDA-regulated reporting activities) are in compliance with this statutory requirement. Given the issues identified in this Guidance, AHRQ will also be engaging in additional inquiry of applicants and PSOs to determine whether the entity is organizationally related to an FDA-regulated reporting entity such that it should be listed as a component PSO (i.e., it is a unit or division of a legal entity, or is owned, managed or controlled by one or more legally separate parent organizations.) If the entity should be listed as a component PSO, AHRQ will work with the entity to pursue such appropriate listing.
The Patient Safety Act includes a provision at 42 U.S.C. § 299b-22(g)(6), the “FDA Rule of Construction,” which states that “[n ]othing in this section shall be construed . . . to limit, alter, or affect any requirement for reporting to the Food and Drug Administration information regarding the safety of a product or activity regulated by the Food and Drug Administration.” (emphasis added.) The Patient Safety Act added sections 921 to 926 to the Public Health Service Act. The “section” that is referenced in the FDA Rule of Construction is section 922 of the Public Health Service Act, 42 U.S.C. § 299b-22, which includes all of the Patient Safety Act’s privilege and confidentiality protections and exceptions. Thus, the privilege and confidentiality protections in the Patient Safety Act cannot be construed to limit, alter, or affect any requirement for reporting information to the FDA regarding the safety of an FDA-regulated product or activity.
The confidentiality requirements of the Patient Safety Act do not apply to or prohibit a “[d]isclosure by a provider to the Food and Drug Administration with respect to a product or activity regulated by the Food and Drug Administration .” 42 U.S.C. § 299b-22(c)(2)(D). The final rule implementing the Patient Safety Act regulation at 42 CFR 3.206(b)(7)(i) provides that the confidentiality provisions shall not apply to or prohibit: "Disclosure by a provider of patient safety work product concerning an FDA-regulated product or activity to the FDA, an entity required to report to the FDA concerning the quality, safety, or effectiveness of an FDA-regulated product or activity, or a contractor acting on behalf of FDA or such entity for these purposes.” Subsection (b)(7)(ii) provides that: “Any person permitted to receive patient safety work product pursuant to paragraph (b)(7)(i) of this section may only further disclose such patient safety work product for the purpose of evaluating the quality, safety, or effectiveness of that product or activity to another such person or the disclosing provider.”1